Systems and methods for universal tail-based indexing strategies for amplicon sequencing
Some embodiments of the invention include a method of preparing a sample for sequencing that includes receiving a sample and amplifying at least one marker within the sample. In some embodiments, amplification of the first marker may include mixing the sample with a first oligonucleotide that comprises a first universal tail sequence and a second oligonucleotide that comprises a second universal tail sequence. In some aspects of the invention, the first universal tail sequence and the second universal tail sequence are different sequences.
1. A sequencing method comprising the steps of:
receiving a sample;
amplifying at least a first marker within the sample to produce at least a first amplicon, wherein the step of amplifying at least the first marker comprises mixing the sample with a first oligonucleotide comprising a first universal tail sequence and a second oligonucleotide comprising a second universal tail sequence, wherein the first universal tail sequence and the second oligonucleotide sequence are different;
adding an index to at least the first amplicon using an indexing oligonucleotide to produce at least a first indexed amplicon, wherein
the indexing oligonucleotide comprises an index sequence and a complementary sequence that recognizes at least one of the first universal tail sequence and the second universal tail sequence, and
the step of adding an index to the first amplicon comprises mixing the first amplicon with the at least one indexing oligonucleotide; and
sequencing the indexed amplicon with at least one sequencing primer, wherein at least one sequencing primer comprises a sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8.
2. The method of claim 1 , wherein the first universal tail sequence and the second universal tail sequence independently comprise a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 4.
3. The method of claim 1 , further comprising:
amplifying a second marker to produce a second amplicon by mixing the sample with a third oligonucleotide comprising the first universal tail sequence and a fourth oligonucleotide comprising the second universal tail sequence; and
adding the index to the second amplicon using the indexing oligonucleotide to produce a second indexed amplicon, wherein the step of adding an index to the second amplicon comprises mixing the second amplicon with the at least one indexing oligonucleotide.
4. The method of claim 3 , wherein the steps of amplifying the first marker and the second marker occur in a multiplex polymerase chain reaction.
5. The method of claim 1 , wherein the at least one indexing oligonucleotide comprises a complementary sequence that recognizes at least one of the first universal tail sequence and the second universal tail sequence at the 3′ end and the index sequence at the 5′ end.
6. The method of claim 5 , wherein the at least one indexing oligonucleotide comprises a sequence selected from the group consisting of SEQ ID NOs: 9-44.
7. The method of claim 1 , wherein the sample comprises a pathogenic organism selected from the group consisting of Mycobacterium tuberculosis, Burkholderia pseudomallei, Burkholderia mallei , and Leptospira sp.
8. The method of claim 1 , wherein the first marker comprises an antibiotic resistance gene.
9. The method of claim 1 , wherein the sample comprises castor beans, castor bean derivatives, and/or tissue from a human.
10. A method of producing sequencing platform-ready amplicons from a sample, the method comprising the steps of:
receiving a sample;
amplifying at least a first marker within the sample to produce at least a first amplicon, wherein the step of amplifying at least the first marker comprises mixing the sample with a first oligonucleotide comprising a first universal tail sequence and a second oligonucleotide comprising a second universal tail sequence, wherein the first universal tail sequence and the second oligonucleotide sequence are different; and
adding an index to at least the first amplicon using an indexing oligonucleotide to produce at least a first indexed amplicon, wherein
the indexing oligonucleotide comprises a sequence selected from the group consisting of SEQ ID NOs: 9-44,
the step of adding an index to the first amplicon comprises mixing the first amplicon with the at least one indexing oligonucleotide, and
the indexed amplicon is sequencing ready.
11. The method of claim 10 , wherein the first universal tail sequence and the second universal tail sequence independently comprise a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 4.
12. The method of claim 10 , further comprising:
amplifying a second marker to produce a second amplicon by mixing the sample with a third oligonucleotide comprising the first universal tail sequence and a fourth oligonucleotide comprising the second universal tail sequence; and
adding the index to the second amplicon using the indexing oligonucleotide to produce a second indexed amplicon, wherein the step of adding an index to the second amplicon comprises mixing the second amplicon with the at least one indexing oligonucleotide.
13. The method of claim 12 , wherein the steps of amplifying the first marker and the second marker occur in a multiplex polymerase chain reaction.
14. The method of claim 10 , wherein the sample comprises a pathogenic organism selected from the group consisting of Mycobacterium tuberculosis, Burkholderia pseudomallei, Burkholderia mallei , and Leptospira sp.
15. The method of claim 10 , wherein the first marker comprises an antibiotic resistance gene.
16. The method of claim 10 , wherein the sample comprises castor beans, castor bean derivatives, and/or tissue from a human.
17. The method of claim 10 , further comprising sequencing the indexed amplicon with at least one sequencing primer.
18. The method of claim 17 , wherein the sequencing primer comprises a sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8.